Avelead Expands Agreement with Large Provider Network for Compare Solution

 National Health System Chooses Compare Solution to Assist with

EHR Conversions and Enhance Data Quality 

Atlanta, GA, Aug. 01, 2022 (GLOBE NEWSWIRE) — Avelead, a Streamline Health Company (Nasdaq: STRM), today announced an expansion of its existing relationship with a Southwest-based healthcare system with more than 60 acute care facilities in the United States. The health system has agreed to expand its use of Avelead’s Compare solution to three additional facilities to assist in their transitions to a new electronic health record (EHR). 

Avelead’s mission is to help hospitals put an end to lost revenue. Avelead’s flagship RevID solution eliminates leaking revenue before it happens by helping identify, review and reconcile potential charge mistakes prior to billing. Avelead’s Compare solution assists organizations with automation that compiles and compares common data from disparate systems during large-scale migrations such as EHR conversions. By ensuring data quality, Compare expedites the transition to new systems and the subsequent operational and financial benefits of using them. 

“As hospitals adapt to new challenges and adopt new technologies, our Compare solution enables successful system transitions,” stated Jawad Shaikh, President and CEO, Avelead. “Providing visibility into the common data being migrated from legacy systems to newer ones enables organizations to identify potential issues and proactively address them, minimizing the disruptions normally encountered with such large projects. We’re honored to expand this relationship and build on the trust we’ve developed by optimizing our client’s processes and outcomes going forward.” 

About Avelead

Avelead, a Streamline Health Company, empowers hospitals and health systems to thrive by eliminating leaking revenue from every healthcare setting. With Avelead’s results-based software, hospitals can proactively identify discrepancies, centralize data, and confirm revenue capture for improved financial performance. Avelead’s unique healthcare solutions currently support more than 140 providers across the country. 

For more information about Avelead’s services and solutions, visit www.avelead.com 

About Streamline Health

Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net.

To Learn More 

Media

David Kosloski
Sr. Director, Marketing & Communications
651.308.1395
david.kosloski@streamlinehealth.net

Investors

Jacob Goldberger
Director, Investor Relations and FP&A
303.887.9625
jacob.goldberger@streamlinehealth.net

Staff

Recent Posts

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

1 hour ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

1 hour ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

1 hour ago

RazorMetrics Drives More Than $11 Million in Prescription Drug Savings for Ohio Plans and Residents

AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy cost containment…

1 hour ago

NYSE Content Advisory: Pre-Market Update + Cast of HBO’s ‘Industry’ Rang Thursday’s Closing Bell

NEW YORK, Jan. 30, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…

1 hour ago

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

HENDERSON, Nev., Jan. 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national…

1 hour ago